Expert opinion on the use of biological therapy in non-infectious uveitis. (4th May 2019)

• Record Type: Journal Article
• Authors: Touhami, Sara; Diwo, Eléonore; Sève, Pascal; Trad, Salim; Bielefeld, Philip; Sène, Damien; Abad, Sebastien; Brézin, Antoine; Quartier, Pierre; Koné Paut, Isabelle; Weber, Michel; Chiquet, Christophe; Errera, Marie-Hélène; Sellam, Jérémie; Cacoub, Patrice; Kaplanski, Gilles; Kodjikian, Laurent; Bodaghi, Bahram; Saadoun, David
• Is Part Of: Expert opinion on biological therapy. Volume 19:Number 5(2019)
• Page Start: 477
• Page End: 490
• Publication Date: 2019-05-04
• Subjects: Anti-TNF alpha -- biotherapy -- immunosuppressive treatment -- uveitis; Gene therapy -- Periodicals; Protein drugs -- Periodicals; Peptide drugs -- Periodicals; Immunotherapy -- Periodicals; Drug delivery systems -- Periodicals; 615.5
• DOI: 10.1080/14712598.2019.1595578
• Languages: English
• ISSNs: 1471-2598

Abstract

ABSTRACT: Introduction: Conventional immunosuppressive drugs, anti-TNF alpha treatments and biotherapies are increasingly being used in non-infectious uveitis. Areas covered: The present work was led by a multidisciplinary panel of experts, including internal medicine specialists, rheumatologists and ophthalmologists, and proposes an extensive review on the use of biological agents in non-infectious uveitis. Expert opinion: In case of dependency to steroids or sight-threatening disease, conventional immunosuppressive drugs (methotrexate, azathioprine and mycophenolate mofetil) and/or biological therapies such as anti-TNF alpha treatments (adalimumab, infliximab) can be used to achieve and maintain disease quiescence. Interferon is an efficient immunomodulatory drug that can be proposed as second-line therapy in specific indications (eg. refractory macular edema, sight-threatening Behçet's uveitis). Other biologics, especially tocilizumab, are showing promising results. Local treatments (steroids, sirolimus etc.) can be used as adjuvant therapies in case of unilateral relapse. Therapeutic response must always be evaluated by clinical examination and appropriate ancillary investigations.